Variants associated with meconium ileus in cystic fibrosis were identified in 3,763 affected individuals by genome-wide association study (GWAS). Five SNPs at two loci near SLC6A14
at Xq23-24 (minimum P = 1.28 × 10 −12 at rs3788766) and SLC26A9 at 1q32.1 (minimum P = 9.88 × 10 −9 at rs4077468) accounted for ~5% of phenotypic variability and were replicated in an independent sample of affected individuals (n = 2,372; P = 0.001 and 0.0001, respectively). By incorporating the knowledge that disease-causing mutations in CFTR alter electrolyte and fluid flux across surface epithelium into a hypothesis-driven GWAS (GWAS-HD), we identified associations with the same SNPs in SLC6A14 and SLC26A9 and established evidence for the involvement of SNPs in a third solute carrier gene, SLC9A3. In addition, GWAS-HD provided evidence of association between meconium ileus and multiple genes encoding constituents of the apical plasma membrane where CFTR resides (P = 0.0002; testing of 155 apical membrane genes jointly and in replication, P = 0.022). These findings suggest that modulating activities of apical membrane constituents could complement current therapeutic paradigms for cystic fibrosis.
Cystic fibrosis is caused by mutations in the CFTR gene encoding the cystic fibrosis transmembrane conductance regulator 1 . The CFTR protein is a chloride channel located on the apical membrane of the surface epithelium, where ion conduction and solute trafficking contribute to the regulation of transepithelial fluid flow. Individuals with the same loss-of-function CFTR mutations have variable disease severity and different cystic fibrosis-associated effects on organs, including the lung, pancreas, liver, intestine and vas deferens; thus, additional features, including variation in other genes (referred to as modifier genes), may affect disease pathophysiology. Approximately 15% of individuals with cystic fibrosis have severe intestinal obstruction at birth, a complication known as meconium ileus 2 . Meconium ileus develops in utero and presents following birth with complete intestinal obstruction that requires either enema or surgical intervention. This neonatal complication is highly indicative of cystic fibrosis, occurs in either sex, shows notable heritability exceeding 88% (ref. 3) and is likely minimally affected by environmental influences.
The North American Cystic Fibrosis Gene Modifier Consortium has accumulated 3,763 participants with severe (pancreatic exocrineinsufficient) CFTR alleles and genome-wide genotype data at 543,927 SNPs 4, 5 (Table 1 and Online Methods). The definition of meconium ileus was consistent within the consortium, and disease status for each subject was recorded following rigorous chart review. A conventional GWAS for meconium ileus used a generalized estimating equations (GEE) model 6 to include collected sibling pairs and led to the identification of five SNPs that associated with genome-wide significance (P < 5 × 10 −8 ) 7 from two regions that include SLC26A9 on chromosome 1 and SLC6A14 on the X chromosome ( Fig. 1, Table 2 and Supplementary Fig. 1 ;
Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis sex-specific results are given in Supplementary Table 1) . CFTR genotype (encoding p.Phe508del) was not a significant confounder or effect modifier when incorporated into the GWAS ( Supplementary Fig. 2 and Supplementary Table 2 ). We then replicated the associations at SLC6A14 (minimum P = 0.001) and SLC26A9 (minimum P = 0.0001) with meconium ileus in an independent combined collection from North America and France ( Table 2) .
The signal intensity plots of the associated SNPs reflected autosomal and X-associated SNPs at SLC26A9 and SLC6A14, respectively. Imputation analysis using MACH and minimac 8, 9 identified the same regions of association as for the genotyped SNPs (Online Methods and Supplementary Fig. 3 ). The five associated SNPs in SLC6A14 and two in SLC26A9 (Fig. 1b,c) are positioned just upstream of the respective transcription start sites, such that binding of activating or repressing transcription factors might be affected, as highlighted by ENCODE data 10 (data not shown). Neither SLC6A14 nor SLC26A9 coding regions showed evidence of copy-number variants (CNVs); however, there was a gap in the reference sequence more than 10 kb upstream of the SLC26A9 locus.
The seven SNPs genotyped in the two genes ( (1,702:1,450) a Size of cystic fibrosis subject sample used for the meconium ileus GWAS and GWAS-HD discovery study is given by consortium site. The TSS contained sibling pairs. There were 3,199 unrelated individuals among the total of 3,763 studied. b Meconium ileus (MI) status is given separately for each center. c Gender breakdown is indicated for each subject category.
l e t t e r s npg l e t t e r s account for heterogeneity. We therefore proposed a GWAS that took a hypothesis into consideration, which therefore is hypothesis driven (GWAS-HD), to systematically prioritize SNPs for genome-wide analysis. The highest priority markers were also evaluated as a set to test the statistical significance of the hypothesis used for prioritization ( Supplementary Fig. 4 ). GWAS-HD prioritization in the context of cystic fibrosis was based on the knowledge that a major source of pathophysiology in cystic fibrosis is impaired fluid and electrolyte flux in the epithelium of cystic fibrosis-affected organs. The polarized epithelial layer forms a highly selective barrier for organ surface and ductal linings. Transepithelial function is achieved by cell polarization, wherein many determinants and regulators of fluid, solute and ion transport reside at the apical membrane alongside CFTR, with other features contributing from the basolateral surface. We have shown in a mouse model that CFTR function in the gastrointestinal epithelium is critical for preventing intestinal obstructions 12 . Thus, we hypothesized that with loss of CFTR genetic variation in other apical membrane constituents could modify cystic fibrosis phenotypes, such as meconium ileus.
A list of 157 gene products ( Fig. 2 and Supplementary Table 3 ) was annotated to be localized to the apical plasma membrane using AmiGO 13 with Gene Ontology data 14, 15 . CFTR and many solute transporters were included in this list. However, the protein SLC6A14 was not on the list, despite being annotated as residing in the highly specialized brush border intestinal membrane, which shows a limitation of the GO annotation that we accepted without additional curation to avoid bias. In total, 3,814 GWAS SNPs were within 10 kb of the boundaries of 155 genes on the list of apical membrane genes (according to NCBI36/hg18), whereas 2 genes were not tagged by any of the GWAS SNPs.
To implement the GWAS-HD for meconium ileus using the apical membrane hypothesis, we first prioritized the genome-wide markers by assigning the 3,814 SNPs of the apical membrane genes to a high-priority group and all remaining genome-wide SNPs to a lowpriority group. We then performed two statistical analyses (Online Methods and Supplementary Fig. 4 ). In the first, which was analogous to a conventional GWAS, we conducted single-SNP association analysis using all of the 543,927 GWAS SNPs at the genome-wide level, but we up-weighted the 3,814 apical membrane SNPs via the stratified false discovery rate (SFDR) control 16 . In the second analysis, which focused on only the 3,814 high-priority SNPs, we used multi-SNP analysis to test the prioritization hypothesis itself to determine whether multiple proteins present on the apical plasma membrane contribute to meconium ileus susceptibility.
As in the conventional GWAS, SNPs from SLC6A14 showed the strongest evidence for association with meconium ileus in the single-SNP GWAS-HD analysis ( Supplementary Fig. 5 ), despite not being in the high-priority group, reflecting the robustness of Chr., chromosome; MI, meconium ileus; OR, odds ratio.
a The North American replication collection consisted of 1,140 individuals that correspond to the continuing enrolment at the North American sites. The French replication cohort consisted of 1,232 subjects collected at 38 French cystic fibrosis centers (Online Methods). The French samples were genotyped genome wide with the Illumina 660W-Quad BeadChip platform, and the North American replication samples were genotyped at the six SNPs using TaqMan Assays-on-Demand. b The combined replication P value was calculated using the inverse-variance method, most powerful when different studies have the same direction of effect. The corrected type 1 error for the replication study was 0.007, using the conservative Bonferroni correction for the seven SNPs tested. c Meconium ileus status (MI:non-MI) breakdown for each site. d There was another significantly associated SNP on chromosome 1 (rs4077469, P = 9.88 × 10 −9 ) that was not included, as it is separated by only 128 bp from rs4077468 and is in perfect LD with this SNP. Figure 2 The apical membrane hypothesis identifies genes associated with meconium ileus. A list of 157 genes was annotated using the AmiGO tool 13 based on Gene Ontology data 14 . In total, 3,814 GWAS SNPs were within 10 kb of the boundaries of 155 genes (NCBI36/hg18). Two genes were not tagged by any of the GWAS SNPs, and SLC6A14 was not annotated to the apical plasma membrane. (a) Quantile-quantile plot of the apical membrane SNPs in the discovery sample. The observed association statistics (red) and the statistics calculated from the 10,000 phenotype-permutated replicates (gray) are shown. (b) Statistical significance of the apical membrane hypothesis in the discovery sample. Statistical significance (permutation P = 0.0002) was established via a statistic that summed over the association evidence (Wald c npg l e t t e r s SFDR 17 . In addition, SNPs from SLC26A9 and two other apical genes, ATP2B2 and SLC9A3, showed association evidence with q values of <0.05 (Table 3) . A gene-based analysis (Online Methods) of ATP2B2 (P = 0.0006) and SLC9A3 (P = 0.0001) provided evidence for allelic heterogeneity, as seen in comparing gene-level results to those from single-SNP analysis ( Table 3 ). The association with SLC9A3 at the gene level was replicated in the French cohort (P = 0.017), whereas the association with ATP2B2 at the gene level was not (P = 0.283) (Supplementary Table 3) . Next, restricting analysis to the 3,814 SNPs annotated to the 155 apical membrane genes (which did not include SLC6A14), we tested the apical membrane prioritization hypothesis as part of the GWAS-HD. In this analysis, we observed evidence of association at genome-wide significance between meconium ileus and multiple genes encoding constituents of the apical plasma membrane (permutation P = 0.0002, testing all 3,814 SNPs jointly and not subject to multiple hypothesis testing; Fig. 2a,b) . Even with the exclusion of SLC26A9 (as well as SLC6A14), the apical membrane hypothesis remained significant (P = 0.0058). Thus, GWAS-HD further establishes the involvement of other genes coding for apical membrane constituents, despite insufficient power to detect individual SNPs, even within the context of our prioritized GWAS. For comparison, we also constructed a null hypothesis list of genes encoding nuclear membrane-localized proteins. As expected, the 224 GO-annotated nuclear envelope genes tagged by 3,537 GWAS SNPs showed no relationship with meconium ileus (permutation P = 0.4639; Fig. 3) .
The French cohort with genome-wide data provided independent validation of the apical membrane hypothesis (permutation P = 0.022; Fig. 2c,d and Online Methods). The statistical significance of this gene set (which excluded SLC6A14) in the French cohort remained after also excluding SLC26A9 (P = 0.021) and then both SLC26A9 and SLC9A3 (P = 0.023). Although analysis of the apical membrane hypothesis in a larger independent cohort should be considered as part of future efforts, replication in the smaller French cohort supports a common mechanism of contributing genes across the two study populations.
To determine which apical membrane genes were driving the association, the degree of genetic heterogeneity in meconium ileus and the common contributors across the French and North American samples, we implemented Lasso 18 . In the North American sample, we jointly analyzed all 3,740 SNPs in the apical membrane genes (including in SLC26A9 and SLC9A3), as well as SNPs in SLC6A14, that were not in perfect linkage disequilibrium (LD) (Online Methods). Forty-eight SNPs spanning 36 different genes were retained by Lasso in the multivariate regression model (Supplementary Table 3) . These SNPs jointly explained ~17% of the meconium ileus variation in the North American sample. The percentage explained by the same 48 SNPs in the French sample was 8.1% (Online Methods), with the drop presumably reflecting genetic heterogeneity and the smaller sample size of this replication test collection. We then tested the significance of a score for each individual in the French cohort that was constructed from a weighted sum of the number of risk alleles (defined in the North American sample) across the 48 SNPs 19 . The significant association between meconium ileus and this score (P = 0.0137; Online Methods) provided additional complimentary Chr., chromosome.
a The q value is a genome-wide adjusted P value that controls the false discovery rate. b The rank indicates the genome-wide ordering of the SNPs based on the original association evidence (GWAS) or the SFDR q value after incorporating the apical plasma membrane hypothesis (GWAS-HD). The GWAS and GWAS-HD rank results of all 543,927 SNPs are provided in supplementary Figure 5 . c Apical indicates whether a gene was (1) Figure 3 Assessment of the nuclear envelope null hypothesis. A list was generated of 231 genes associated with the nuclear envelope, as defined by GO annotation. In total, 3,537 GWAS SNPs were within 10 kb of the boundaries of 224 tagged genes (NCBI36/hg18). A priori, the nuclear envelope list should not contain genes associated with meconium ileus (under the null of no association). (a) Quantile-quantile plot of SNPs in the nuclear envelope genes in the discovery sample. The observed association statistics (red) and the statistics calculated from the 10,000 phenotypepermutated replicates (gray) are shown. (b) Statistical significance of the nuclear envelope hypothesis in the discovery sample. Statistical evaluation indicates that genes listed in the nuclear envelope are, as expected, not significantly associated with meconium ileus (permutation P = 4639/10,000 = 0.4639); that is, 4,639 replicates have more extreme sum statistics (gray) than the observed data (vertical red line).
npg l e t t e r s evidence of common contributors between the two cohorts, with SNPs in SLC9A3 and SLC6A14 being two specific examples. In summary, a conventional GWAS identified SNPs in SLC6A14 and SLC26A9 to be significantly associated with meconium ileus. GWAS-HD single-SNP analysis identified the same SNPs in SLC6A14 and SLC26A9, as well as SNPs in SLC9A3, and GWAS-HD multi-SNP analysis spanning 155 genes provided evidence that multiple constituents of the apical plasma membrane are collectively associated with meconium ileus. GWAS-HD can also be applied to other Mendelian disorders or even to complex traits, provided that there is a hypothesis based on underlying biology and that a list of participating, relevant genes can be compiled.
Although gene prioritization has been used in other approaches, such as pathway or gene enrichment analyses [20] [21] [22] , its use in GWAS-HD involves key differences. First, in contrast to the previous inclusionexclusion approaches where all genotyped SNPs are not analyzed simultaneously, GWAS-HD performs parallel single-SNP analysis of all GWAS SNPs and multi-SNP analysis focusing on the set of SNPs of interest, respectively. The prioritized single-SNP analysis interrogates all available SNPs via the SFDR control, yet enables increased statistical power for regions favored a priori. For example, SLC6A14 would be omitted by inclusion-exclusion approaches, although it was the highest ranked gene for association with meconium ileus in the GWAS-HD analysis. Second, methods such as interactive pathway analysis can be restrictive, because contributing genes or proteins must relate to each other via direct or indirect links, which may be disturbed when a cog component (such as CFTR) is dysfunctional in the disease state. Although gene products that participate in maturation or delivery of CFTR may be contributory, consideration of local components of processes that may compensate for the ion and fluid flow disturbance in cystic fibrosis is enabled in the apical membrane hypothesis. Third, distinct from an exhaustive search of all plausible interactive pathways, GWAS-HD focuses on a single biological hypothesis and provides statistical significance for all genes involved jointly, alleviating the multiple testing burden.
It should be noted that the specific statistics or models used in our GWAS-HD application, such as SFDR, Lasso and the sum and score statistics, may not be the most powerful ones in any specific setting. For example, the adaptive rank truncated product statistic 23 could be used to identify the common subset of associated apical membrane genes across two samples, and there are alternative weighting and prioritization approaches 24 .
The SLC9A3 gene codes for a sodium-hydrogen exchanger that, when disrupted, has been shown to decrease intestinal obstruction in a cystic fibrosis mouse model 25 . SLC6A14 codes for a sodium-and chloride-dependant neutral and basic amino-acid transporter 26, 27 . SLC26A9 encodes an anion transporter, likely a chloride channel, with multiple modes that include chloride-bicarbonate exchanger and sodium-anion cotransporter capabilities 28 . The SLC26A9 protein has also been reported to physically interact with CFTR 29 and to be influenced by CFTR activity, at least in lung-related tissues 30 .
It is notable that SLC9A3 has previously been associated with infections and pulmonary function in cystic fibrosis 31 . In the consortium discovery sample, rs6864158 (minor allele frequency (MAF) = 0.43) in SLC9A3 was associated with both a quantitative lung phenotype based on multiple forced expired volume in 1 s (FEV1) measurements (P = 0.0003, analyzed previously 5 ) and with meconium ileus (P = 0.0001); this provides evidence that some genes may have a role in multiple cystic fibrosis comorbidities. Both SLC6A14 and SLC26A9 are robustly expressed in human lung epithelium and sweat gland, as well as in intestinal epithelium, as measured by RT-PCR (data not shown). We anticipate that meconium ileus modifier genes may also influence early pathology in other cystic fibrosis-affected organs and could therefore provide important insights into the mechanisms of cystic fibrosis disease severity and comorbidity.
These findings collectively have important practical implications for cystic fibrosis, where therapeutic strategies should consider pharmacologic modulation of epithelial function together with complementary approaches aimed at directly improving the function or delivery of the mutated CFTR gene product to the apical membrane 32 .
URLs. AmiGO, http://amigo.geneontology.org/; Database of Genome Variants, http://projects.tcag.ca/variation/; ENCODE, http://genome.ucsc.edu/ENCODE/; LocusZoom, http://csg.sph. umich.edu/locuszoom/; MACH, http://www.sph.umich.edu/csg/ abecasis/MaCH/index.html; SFDR, http://www.utstat.toronto.edu/ sun/Software/SFDR/.
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Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
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The authors would like to thank the study particpiants, the Cystic Fibrosis Foundation (CFF) Patient Registry, the University of North Carolina DNA Laboratory and the Genome Quebec and McGill University Innovation Centre. We thank I. Wong for technical help with the replication genotyping, the computer specialists from the French study J. Recruitment and inclusion. Individuals with cystic fibrosis and cystic fibrosis-related phenotypes, including impaired lung function 5 and meconium ileus, were collected by the NACFGMC ( Table 1) . The meconium ileus GWAS was restricted to 3,763 subjects with severe (pancreatic exocrine-insufficient) CFTR genotypes who were of European decent. The 1,140 North American replication participants corresponded to the continuing collection at all sites (351 from TSS, 448 from the University of North Carolina at Chapel Hill and Case Western Reserve University and 341 from CGS) with known meconium ileus status or evidence of an abdominal scar.
There are 49 cystic fibrosis centers in France, caring for ~5,000-6,000 individuals with cystic fibrosis. Prospective enrollment of individuals with cystic fibrosis was initiated in 38 centers in 2006. The French replication cohort included 1,362 phenotyped individuals who were enrolled before June 2010, all of whom were over 6 years of age with both parents born in a European country and had two severe CFTR mutations.
Genotyping. NACFGMC GWAS subjects were genotyped simultaneously using the Illumina 610-Quad BeadChip, as previously described 5 . DNA of the North American replication sample was extracted from whole blood or transformed lymphocytes and quantified with fluorimetry. Genotyping was performed with allele-specific fluorescent probes in TaqMan SNP Genotyping Assays (Custom or On-Demand; Applied Biosystems) as recommended. DNA of the French replication sample was obtained from whole blood and hybridized to the Illumina CNV370-Duo BeadChip for the first 299 subjects (those included before June 2009) and the Illumina 660W-Quad BeadChip for the other subjects at the Centre Nationale de Genotypage (CNG).
Quality control filtering. The GWAS discovery subjects were first cleaned together as part of an initial quality control effort by NACFGMC (see ref. 5 for details) and then underwent additional quality control analysis for the purpose of this study. Samples with a heterozygosity proportion of <28% or sex incongruity and those of non-European ancestry, as determined by principal-component analysis using EIGENSTRAT 34 , were excluded. Using identity-by-descent (IBD) estimates from PLINK 35 , 12 cryptic full siblings were identified and adjusted for relationship. Only one randomly selected individual from each of the ten cryptic monozygotic pairs was retained, and parents of two cryptic parent-offspring pairs were removed from further analysis. In total, 3,763 samples were analyzed, among which only 14 individuals had genotype missing rates of >1% (maximum = 2.8%), and 543,927 SNPs with MAF of >2% were analyzed, among which 2,916 had missing rates of >2% (maximum = 10%). The missing rate for all 3,814 apical membrane SNPs and 15 SNPs from SLC6A14 was <2%.
For the North American replication sample, end-point fluorescence was measured with the plate reader component of the 7900HT Real Time PCR System (Applied Biosystems) and analyzed with TaqMan Genotyper software for allele discrimination with call rates of >95%. To insure quality control, 2% of the samples were run in duplicate, and 1% of the samples corresponded to individuals used in the initial GWAS control, with cross-platform concordance rates of >99%.
The French replication samples with missing rates of >5%, sex incongruity or pairwise IBD estimates of >40% were excluded, yielding 1,232 genotyped and phenotyped affected individuals. SNPs present only on the CNV370-Duo chip, with missing rates of >10% or MAF of <6%, were excluded. Overall, 554,792 SNPs were analyzed, of which 256,756 were genotyped on both chips. GO annotation. Gene lists were generated based on annotation of genes encoding apical membrane and nuclear envelope constituents. A list of 157 apical membrane genes was annotated using the AmiGO tool 13 (version 1.7; 28 March 2010) , based on Gene Ontology data 14 (GO:00163245) and using the cell location search phrase 'apical plasma membrane' with restriction to Homo sapiens. A list of 231 nuclear envelope genes was generated on the basis of GO annotation (GO:0005635).
Imputation. Using MACH and minimac 8, 9 , genome-wide imputation was conducted for the 3,763 GWAS subjects. The reference sample was the 87 CEU subjects extracted from the European continental group (EUR) of the 1000 Genomes Project November 2010 release 36 . Imputed genotype data for 7,245,292 SNPs with MAF of >2% and estimated imputation accuracy of >0.3 (MACH R 2 ) were analyzed, and no new regions with evidence of association at genome-wide significance were identified. In SLC26A9 and SLC9A3, the best imputed SNPs were only marginally more significant than any genotyped SNP (5.94 × 10 −9 versus 9.88 × 10 −9 and 1.09 × 10 −5 versus 6.22 × 10 −5 , respectively), whereas in SLC6A14 the minimum P was given by a genotyped SNP.
Statistical methods. Generalized estimating equations (GEE) 6 were used for the GWAS, with an exchangeable correlation structure to account for full sibling relationships in the data (Geeglm function in R). Genotypes were coded additively for autosomal SNPs and SNPs on the X chromosome in females, and 0 and 2 were used for SNPs on the X chromosome in males. A site covariate with four levels (Table 1) was included. Logistic regression in a sample of 3,199 unrelated individuals with the site covariate and the first seven principal components was also conducted, and the results were consistent with the GEE analysis of the full 3,763 subjects. (Therefore, the principal components were not included in subsequent analysis and permutation tests.) The French GWAS used logistic regression with additive genotype coding (PLINK 36 v1.07 for autosomal SNPs and R for X-chromosome SNPs).
GWAS-HD was used to accomplish two goals in parallel ( Supplementary  Fig. 4 ): (i) single-SNP analysis to establish the significance of individual SNPs at the genome-wide level after weighting according to a prioritization hypothesis (for example, the apical membrane hypothesis), analyzing and re-ranking all GWAS SNPs (for example, 543,927 SNPs in the meconium ileus study), and (ii) multi-SNP analysis to test the significance of the prioritization hypothesis itself, by assessing whether the group of SNPs defined by the hypothesis (the 3,814 SNPs annotated to 157 apical membrane genes; Supplementary Table 3) collectively showed significantly smaller P values (or larger association statistics; Fig. 2a,b) than would be expected under the null hypothesis of no association.
To carry out the first task, GWAS SNPs were assigned to a high-priority group (the 3,814 apical membrane SNPs) or a low-priority group (all other 540,113 SNPs). An SFDR 16, 17 was then applied, and q values were calculated separately in each group. A given SNP was determined to have statistical significance if its q value was <0.05; each SNP was re-ranked genome wide according to its q value (the original GWAS P values were used to guide order if q values were identical). This is equivalent to a weighted P-value approach 37 but with robust weights. In the meconium ileus application, the 3,814 apical membrane SNPs were given weight of ~124, and the remaining 540,113 SNPs were given weight of ~0.13.
The second task was to determine the statistical significance of the apical membrane hypothesis used to prioritize the GWAS, which involved testing 3,814 SNPs simultaneously (or 3,420 SNPs in the French replication cohort). The meconium ileus phenotype was permuted (to preserve the LD pattern between SNPs) within data from each consortium site and independently 10,000 times (or 1,000 times in the French cohort). For each permutation sample, corresponding association analysis was performed using GEE, and a sum of the Wald c 1
2
(1 degree of freedom) association statistics of the 3,814 (or 3,420 in the French cohort) SNPs was obtained. The empirical P value was calculated as the proportion of the permutation samples whose sum statistic was larger than that in the observed sample.
The gene-based analysis was similar to the permutation test, with summation limited to the SNPs within 10 kb of the boundaries of each gene. In total, 156 gene-based permutation tests were performed (155 apical membrane genes npg
